deLIVER: Direct Acting Antiviral Effects on the Liver

NCT02938013 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

HCV Coinfection
Liver Disease
HIV

Interventions

DRUG: Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
DRUG: Sofosbuvir/Velpatasvir (SOF/VEL)

Sponsor

Johns Hopkins University